Danish drugmaker Novo Nordisk on Wednesday posted another quarter of rapid profit growth, though the story for once wasn’t its wildly popular weight-loss drugs. Source link Share this:FacebookXLike this:Like Loading... Related Post navigation What next for one of football’s greatest-ever players?How To Navigate A Buyer’s Cold Feet Without Derailing The Deal